Reply AI Film Festival - Announced the Winners of the First International Festival for Short Films Made With Artificial Intelligence
4.9.2024 10:30:00 EEST | Business Wire | Press release
The winners of the first edition of the Reply AI Film Festival have been announced, the competition for authors of original short films made with Artificial Intelligence (AI), conceived by Reply, a leading international group in the creation of new business models enabled by AI and Digital Media. The awards event, organized in collaboration with Mastercard, was held at the Priceless lounge of the Hotel Excelsior in Venice.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240904521664/en/
Reply presents the inaugural Reply AI Film Festival, an international competition where Artificial Intelligence (AI) serves not only as a catalyst for innovation in the realm of creative storytelling but also as a tool for fostering inclusivity among younger generations in video and film production. (Photo: Business Wire)
The award for Best Short Film was given to 'To Dear Me' byGisele Tong, which tells the story of a young woman, tormented by memories of her parents' divorce and her mother's loneliness, struggling with love, feeling lost and distrustful, until she realizes that finding her true self is the key to healing and moving forward.
Second place went to 'One Way' byEgor Kharlamov, a story about how life can offer a second chance even when it seems there's nothing left to lose. The film ponders on what the price of this second opportunity is.
Third place was awarded to 'Jinx' byMansha Totla, thatfocuses on the memories of World War II through the voice of the main character, Jinx Akerkar, and emphasizes on the fragility of life. An intense dedication to those who lost their lives during the war and those who are still affected by that loss today.
The three winning short films were built around the theme "Synthetic Stories, Human Hearts" and were selected from the twelve finalists by an international jury, which was composed of Adam Kulick, Caleb & Shelby Ward, Denise Negri, Filippo Rizzante, Flavio Natalia, Julien Vallée & Eve Duhamel, Monica Riccioni, Paul Trillo, and Rob Minkoff.
To identify the finalists, the jurors reviewed over 1,000 short films submitted from more than 59 countries, including the USA, UK, Italy, Germany, Spain, France, Brazil, China, India, and Korea. AI artists, directors, writers, animators, VFX artists, but also amateurs were in the talent pool who were competing in the contest, preferring the Narratives and Experimental categories, chosen respectively by 38% and 36% of participants - followed by Documentary (14%) and Pilots (12%).
“To Dear Me, inspired by the animated short film Liebestraum by Yan Xiaoxuan, is a letter written by the creative team to girls and women everywhere. The story condenses the experiences of the many girls and women around them - their mothers, friends, and students. Many of these women carry the scars and flaws of their upbringing, lacking love, yearning for love, but unsure how to love. They often swing between love and hatred, desperately trying to hold onto anyone who loves them, investing all their emotions until they get hurt and become afraid to open their hearts again. They can even lose themselves in a web of false pretenses, doubting if they will ever find true love or even retain the ability to express it properly. With this short film, I want to tell these tender souls around me that even if we lose the love of the world, we must still love ourselves. I encourage them to take a good look at their own lives - the good and the bad - as these precious experiences have shaped each of us into the unique individuals we are. Rescue your past self and empower your present self. My dear girls, it has not been easy on this journey of growth, but remember to love yourselves well and give yourselves a warm embrace,” commented Gisele Tong, who was awarded first place in the competition.
“We are very happy to be part of the festival! This is a great honor and joy for us! Technology is moving forward and the fact that today there is such an opportunity to use artificial intelligence as a tool in the creation of movies and animation, is an incredible breakthrough. A story in a movie can now be told by anyone, that's great! It is important to remember that any technology is a tool in the hands of man, an incredibly powerful tool and let it serve for the benefit of mankind. Thank you to the festival for highlighting the first steps of new opportunities!” commented Egor Kharlamov, the second-place winner.
“The Reply AI Film Festival has been an incredible experience and I’m so happy that my film, ‘JINX’ was selected as a finalist. The festival team has been so attentive and the appreciation of my work has motivated me to further believe in myself. I was stuck for the past 3 years as I didn’t simply want to fill in the gaps of my film with random stock footage of the war. Thus, the most significant thing about my film was the use of AI to create WW2 footage that is authentic to my subject’s story. I believe that in the future, AI will transform the filmmaking industry and it’ll be interesting to see how we incorporate AI's capabilities with our human vision and artistic intuition,” commented Mansha Totla, the third-place winner.
“The winners of the Reply AI Film Festival demonstrate how Artificial Intelligence enables the creation of new narratives, innovative, and visually captivating content, while maintaining the essential human element—the vision, heart, and soul of a film,” said Filippo Rizzante, CTO of Reply. “The Reply AI Film Festival has become an important opportunity to highlight innovation and creativity, offering young talent the chance to immerse themselves in new technologies, acquire advanced skills, and create new, more accessible and sustainable creative scenarios.”
“We are pleased to have hosted in Venice the awards event of the Reply AI Film Festival, a competition that enhances the creativity of young film talents, offering them a unique opportunity for interaction and expression,” said Luca Fiumarella, Head of Marketing Italy at Mastercard. “We are committed to promoting initiatives where technology combines with great passions, creating new opportunities to bring people closer to the world of art and cinema. Our goal is to make artistic production more accessible and inclusive, using technological innovation to fuel creativity and support new generations in pursuing their aspirations.”
The Reply AI Film Festival was created by Reply as part of its program to promote new technologies among younger generations. The goal is to foster a culture of innovation and provide a new, stimulating space for experimentation, offering a space where AI can be put to the test as an ally of human creativity and demonstrate that the synergy between people and technologies can enable new scenarios that are more accessible to anyone who possesses the spark of creativity. The competition is part of the Reply Challenges, a program of technological and creative competitions that testify to Reply's commitment to developing innovative educational models capable of engaging new generations. Today Reply's Challenges have a community of more than 150,000 participants.
To see the winning short films and finalists, visit aiff.reply.com.
Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com
Mastercard
Mastercard is an international payments technology company. Our goal is to create connections and promote an inclusive digital economy from which everyone can benefit, wherever they are, through secure, simple, fast and accessible transactions. By being able to rely on secure data and networks, partnerships and passion, and our products and solutions, we help consumers, financial institutions, governments and businesses reach their full potential. With a presence in more than 210 countries and territories, we are building a more sustainable world that offers priceless opportunities for all. www.mastercard.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240904521664/en/
Contacts
Reply
Fabio Zappelli
f.zappelli@reply.com
Irene Caia
i.caia@reply.com
Mastercard
Giuliana Abbate
E. Giuliana.Abbate@mastercard.com
Omnicom PR Group
Ufficio Stampa Mastercard
T. 02 6241 19
E. mln.mastercard@fleishmaneurope.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom